Jubilant Pharmova Ltd.

NSE: JUBLPHARMA | BSE: 530019 | ISIN: INE700A01033 | Industry: Pharmaceuticals
| Mid-range Performer
1079.7000 18.30 (1.72%)
NSE Sep 30, 2025 13:02 PM
Volume: 46,266
 

1079.70
1.72%
Motilal Oswal
JLS reported revenue of INR44b, EBITDA margin of 20.4% and PAT of INR4.1bin 1HFY19. Management reiterated that it is well placed to improve on this performance in 2HFY19.
Jubilant Pharmova Ltd.'s price crossed above 30Day SMA today
More from Jubilant Pharmova Ltd.
Recommended